ZNF385B as a potential prognostic and immunotherapy biomarker in ovarian cancer: insights from pan-cancer analysis

ZNF385B作为卵巢癌潜在的预后和免疫治疗生物标志物:来自泛癌分析的启示

阅读:2
作者:Hang Yu,Wei Cheng,Aoshuang Huang,Jing Feng,Dan Zi

Abstract

Although ZNF385B, a member of the zinc finger protein family, plays important roles in various physiological processes, its involvement in cancer remains poorly understood. In this study, we systematically investigated the expression patterns, prognostic value, and molecular characteristics of ZNF385B across multiple cancer types using data from The Cancer Genome Atlas (TCGA), with a particular focus on ovarian cancer. To support the bioinformatics findings, a series of functional experiments were performed to explore the biological role of ZNF385B. Our analysis revealed that ZNF385B exhibits differential expression across various cancers and is associated with either favorable or unfavorable prognosis depending on the tumor type. Functional enrichment analyses suggest that ZNF385B is involved in critical cellular processes, such as transcriptional regulation, protein modification, and cellular localization. Separately, ZNF385B expression shows a significant correlation with immune cell infiltration in multiple tumor types, implying a potential role in tumor immune modulation and cancer prognosis. These findings provide novel insights into the biological functions of ZNF385B and highlight its potential as a prognostic and immunological biomarker in ovarian and other cancers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。